People's Journal of Scientific Research
Published June 1, 2019 | Version v1
Journal article Open

Betamethasone Induced Hypertrophic Obstructive Cardiomyopathy in Infant

Authors/Creators

  • 1. Department of Pediatrics, *Gandhi Medical College, Bhopal, People's College of Medical Sciences and Research Centre, Bhopal

Description

Hypertrophic obstructive cardiomyopathy (HOCM) is a major potential complication of dexamethasone therapy 
in preterm infants. HOCM may also be caused by Betamethasone in infants if given for longer time. We present a case of a 3 
month old male baby who was prescribed betamethasone by quack for 1 month for treatment of cough and cold. The baby 
developed HOCM and systolic anterior motion of mitral valve which completely resolved after stoppage of betamethasone 
in 12 weeks. 

Files

13.pdf

Files (55.0 kB)

Name Size Download all
md5:472e1949d206ced25f15b97425cf6d72
55.0 kB Preview Download

Additional details

References

  • 1. Robert L S, Stephanie M W. Diseases of myocardium. In: Kliegman R, Stanton B, St. Geme J W, Schor N F, Behrman R E, Editors, Nelson t h Textbook of Pediatrics 20 edition Vol 2 Phialdelphia: Elsevier. 2016. p. 2271-2278. 2. Jan Klimas, Drug-Induced Cardiomyopathies, Cardiomyopathies - From Basic Research to Clinical Management, Prof. Josef Veselka (Ed.), 2012 ISBN: 978-953-307-834-2 3. American Academy of Pediatrics, Committee on Fetus and Newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics. 2002;109:330–338 4. Zecca E, Papacci P, Maggio L, Gallini F, Elia S, Rosa G. Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial J Clin Pharmacol. 2001;41:1075–1081. 5. Hattori T, Murase T, Iwase E, Takahashi1 K, Ohtake M, Tsuboi K. Glucocorticoid induced hypertension and cardiac injury: effects of mineralocorticoid and glucocorticoid receptor antagonism. Nagoya J Med Sci. 2013;75:81- 92. 6. Werner JC, Sicard RE, Hansen TWR Solomon E, Cowett RM, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysphasia. J Pediatr. 1992; 120: 286–291. 7. Bensky AS, Kothadia JM, Covitz W. Cardiac effects of dexamethasone in very low birth weight infants. Pediatr. 1996; 97: 818–821. 8. Young RS, Fripp RR, Stern DR, Darowish C. Cardiac hypertrophy associated with ACTH therapy for childhood seizure disorder. J Child Neurol. 1987; 2: 311–312. 9. Alpert BS. Steroid-induced hypertrophic cardiomyopathy in an infant. Pediatr Cardiol. 1984; 5:117–118. 10. Skelton R, Gill AB, Parsons JM. Cardiac effects of short course dexamethasone in preterm infants. Arch Disc Child Fetal Neonatal Ed. 1998; 78: F133- F137.
  • 11. Balys R, Manoukian J, Zalai C. Left ventricular hypertrophy with outflow tract obstruction—a complication of dexamethasone treatment for subglottic stenosis. Int J Pediatr Otorhinolaryngol. 2005; 69:271–273. 12. Scire` G, D'Anella G, Cristofori L, Mazzuca V, Cianfarani S. Marked left ventricular hypertrophy mimicking hypertrophic cardiomyopathy associated with steroid therapy for congenital adrenal hyperplasia. J Cardiovasc Med. 2007; 8:465–467.